Float Short %

4.97

Margin Of Safety %

-28

Put/Call OI Ratio

0.08

EPS Next Q Diff

0.25

EPS Last/This Y

75.31

EPS This/Next Y

0.19

Price

324

Target Price

355

Analyst Recom

2.12

Performance Q

9.3

Relative Volume

Beta

1.18

Ticker: BIO

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-09	BIO	308.03	0.17	0.00	562
2025-12-10	BIO	314.84	0.17	0.00	554
2025-12-11	BIO	314.08	0.17	0.00	554
2025-12-12	BIO	308.11	0.16	0.00	572
2025-12-15	BIO	307.64	0.12	0.00	722
2025-12-16	BIO	302.13	0.12	0.00	722
2025-12-17	BIO	301.31	0.12	0.00	724
2025-12-18	BIO	299.7	0.13	2.00	691
2025-12-19	BIO	300.93	0.13	0.01	693
2025-12-22	BIO	305.25	0.11	0.00	375
2025-12-23	BIO	301.02	0.11	0.00	371
2025-12-26	BIO	303.88	0.11	0.00	373
2025-12-29	BIO	303.39	0.11	0.00	377
2025-12-30	BIO	304.93	0.09	0.00	454
2025-12-31	BIO	303.01	0.09	0.00	454
2026-01-02	BIO	305.4	0.09	0.50	458
2026-01-05	BIO	322.36	0.09	0.00	463
2026-01-06	BIO	325.61	0.07	0.00	565
2026-01-07	BIO	324.14	0.08	0.00	522
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-09	BIO	308.05	-5.2	1116.7	9.98
2025-12-10	BIO	308.05	-5.2	1124.1	9.98
2025-12-11	BIO	313.97	-5.2	1117.6	9.98
2025-12-12	BIO	308.31	-5.2	1112.4	9.98
2025-12-15	BIO	307.92	-5.2	1116.9	9.98
2025-12-16	BIO	307.92	-5.2	1110.8	9.98
2025-12-17	BIO	301.11	-5.2	1114.9	9.98
2025-12-18	BIO	299.69	-6.6	1114.0	9.95
2025-12-19	BIO	301.41	-6.6	1117.1	9.95
2025-12-22	BIO	304.53	-6.6	1119.0	9.95
2025-12-23	BIO	300.39	-6.6	1111.8	9.95
2025-12-26	BIO	303.86	-6.6	1118.1	9.95
2025-12-29	BIO	303.49	-6.6	1115.9	9.95
2025-12-30	BIO	304.74	-6.6	1121.8	9.95
2025-12-31	BIO	303.03	-6.6	1119.3	9.95
2026-01-02	BIO	305.35	-6.6	1123.1	9.95
2026-01-05	BIO	322.27	-6.6	1139.5	9.95
2026-01-06	BIO	325.36	-6.6	1127.7	9.95
2026-01-07	BIO	324.00	-6.6	1123.6	9.95
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-09	BIO	-0.01	3.13	4.80
2025-12-10	BIO	-0.01	3.13	5.46
2025-12-11	BIO	-0.01	3.13	5.46
2025-12-12	BIO	-0.01	3.13	5.46
2025-12-15	BIO	-0.01	3.13	5.46
2025-12-16	BIO	-0.01	3.13	5.46
2025-12-17	BIO	-0.01	3.13	5.46
2025-12-18	BIO	-0.01	3.13	5.46
2025-12-19	BIO	-0.01	3.13	5.46
2025-12-22	BIO	-0.01	3.16	5.46
2025-12-23	BIO	-0.01	3.16	5.46
2025-12-26	BIO	-0.01	3.16	4.97
2025-12-29	BIO	-0.01	3.15	4.97
2025-12-30	BIO	-0.01	3.15	4.97
2025-12-31	BIO	-0.01	3.15	4.97
2026-01-02	BIO	-0.01	3.15	4.97
2026-01-05	BIO	-0.01	4.64	4.97
2026-01-06	BIO	-0.01	4.64	4.97
2026-01-07	BIO	-0.01	4.64	4.97
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

2.26

Avg. EPS Est. Current Quarter

2.71

Avg. EPS Est. Next Quarter

2.51

Insider Transactions

-0.01

Institutional Transactions

4.64

Beta

1.18

Average Sales Estimate Current Quarter

694

Average Sales Estimate Next Quarter

602

Fair Value

232.6

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

61.1

Max Drawdown 5-Year %

-73.8

Target Price

355

P/E

Forward P/E

30.29

PEG

5.87

P/S

3.42

P/B

1.3

P/Free Cash Flow

25.99

EPS

-24.3

Average EPS Est. Cur. Y

9.95

EPS Next Y. (Est.)

10.15

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-26.43

Relative Volume

Return on Equity vs Sector %

-37.1

Return on Equity vs Industry %

-27.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.09

EBIT Estimation

1123.6

Bio-Rad Laboratories, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 7700

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

stock quote shares BIO – Bio-Rad Laboratories, Inc. Stock Price stock today

news today BIO – Bio-Rad Laboratories, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch BIO – Bio-Rad Laboratories, Inc. yahoo finance google finance

stock history BIO – Bio-Rad Laboratories, Inc. invest stock market

stock prices BIO premarket after hours

ticker BIO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: BIO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y